跳至主要内容
临床试验/JPRN-jRCTs021180043
JPRN-jRCTs021180043已完成未知

Estimating the efficacy of the oral alkalizers in patients with chronic kidney disease.

Abe Michiaki0 个研究点目标入组 101 人开始时间: 2019年3月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
101

研究概览

简要总结

There are no changes on primary endpoint. For secondary endpoint, treatment by sodium/potassium citrate could increase morning-urine pH and might improve serum creatinine and eGFR-Cr. The limitation of the study is low number of the registration.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 80age old(—)
性别
All

入选标准

  • 1) A patient with chronic kidney disease and age >= 20, < 81 years.
  • 2) Signed and dated informed consent document indicating that patient has been informed of all pertinent aspects of this trial prior to enrollment.

排除标准

  • 1) Serious heart disease or liver disease.
  • 2) Patients with alkaline urine.
  • 3) Patients who are judged unfit to enroll in this trial by the investigator.

研究者

发起方
Abe Michiaki

相似试验